[Controlled clinical study of an association of cresotamide and d-propoxyphene phenylbutazonate in (Midalgyl) in urology].
D000328:Adult; D000368:Aged; D000893:Anti-Inflammatory Agents / Q000627:therapeutic use*; D002986:Clinical Trials as Topic; D003408:Cresols / Q000627:therapeutic use; D011431:Dextropropoxyphene / Q000031:analogs & derivatives* / Q000627:therapeutic use; D004338:Drug Combinations; D004341:Drug Evaluation; D005260:Female; D006801:Humans; D008297:Male; D008875:Middle Aged; D010653:Phenylbutazone / Q000627:therapeutic use*; D012457:Salicylamides / Q000627:therapeutic use*; D014570:Urologic Diseases / Q000188:drug therapy*
D000893:Anti-Inflammatory Agents; D003408:Cresols; D004338:Drug Combinations; D012457:Salicylamides; D010653:Phenylbutazone; D011431:Dextropropoxyphene
Sperimentazione clinica controllata dell'associazione cresotamide e fenilbutazonato di d-propossifene (Midalgyl) in urologia